Citi lowered the firm’s price target on IFF (IFF) to $75 from $82 and keeps a Buy rating on the shares as part of a Q3 preview for the specialty chemicals group. The firm continues to see a challenging macro environment for the group with volumes underperforming across end markets.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IFF: